Retraction notice to “Corrigendum to ‘Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer’ [International Journal of Biological Macromolecules 248 (2023) 125782]” (International Journal of Biological Macromolecules (2023) 248, (S0141813023026776), (10.1016/j.ijbiomac.2023.125782))
5
